Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer
Clinical trial NCT03983395 · TERMINATED
Trial details
- NCT number
- NCT03983395
- Sponsor
- Ichnos Sciences SA
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-08
- Primary completion
- 2020-07-24
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.